Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Snufflebabe
- Development stage
- Unknown
- Lead developer
- Phoenix Laboratories
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Inhalation, Intranasal, Topical
01
Overview
Snufflebabe is a leading pediatric decongestant brand designed to relieve nasal congestion and support comfortable breathing, feeding, and sleeping in infants and young children. Originally developed by DDD Limited (Dendron Brands) and acquired by Phoenix Laboratories in 2020, the Snufflebabe range includes both medicinal and supportive care products. The flagship product, Snufflebabe Vapour Rub, is a topical ointment containing a combination of eucalyptus oil, menthol, and thyme oil, which release soothing aromatic vapours to ease congestion in babies from three months of age. The range also features Snufflebabe Nasal Drops and Nasal Spray, which utilize a gentle 0.9% saline (sodium chloride) solution suitable from birth to naturally loosen mucus and clear nasal passages, often used in conjunction with the Snufflebabe Nasal Aspirator medical device.
- Brand names
- Snufflebabe
02
Targets
TRPM8 (Transient receptor potential cation channel subfamily M member 8)
Beyond the preview
Go deeper on Snufflebabe.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Snufflebabe.